Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

TAG:

the clinical laboratory

Where Is the FDA When Labs Need It Most?

LET’S START WITH AN ESSENTIAL FACT: in the management of almost everyĀ outbreak of a novel infectious disease, clinical laboratory tests will be essentialĀ in diagnosis of the disease, in monitoring the progress of an infected patient,Ā and in determining if, once cured, a patient has immunity to tha…

Read More



COVID-19 Serology Test Review: FDA Says 8 of 11 Tests Fail

CEO SUMMARY: After introducing some 200 serological assays onto the market in March and April with little or no review, as of this writing the FDA website lists only 77 serology tests. Of that number, 11 assays have been evaluated independently andĀ eight of those 11 have been pulled from…

Read More



Questions Arise as FDA Assesses Serology Tests

CEO SUMMARY: On June 4, the FDA released results of anĀ evaluation of some of the 20 tests offered for sale in this countryĀ to identify antibodies for SARS-CoV-2. A quality control expert inĀ clinical labs called the antibody test analysis deeply flawed in partĀ because of the studyā€™s …

Read More



June 22, 2020 Intelligence: Late-Breaking Lab News

As they scrambleĀ to respond to theĀ COVID-19 pandemic,Ā federal officials in multipleĀ agencies are purchasingĀ equipment and supplies fromĀ vendors with dubious credentialsĀ and little operatingĀ history. In recent days, Pro-Publica reported ā€œa fledglingĀ Texas company was paid $7.3Ā mil…

Read More



COVID-19 Pandemic Erodes Cash Flow at Clinical Labs

CEO SUMMARY: Every day, national news headlines screamĀ about the shortage of SARS-CoV-2 lab tests needed to manageĀ the COVID-19 pandemic. Recently, national news coverageĀ has begun focusing on concerns about inaccurate or unreliableĀ COVID-19 serology tests. But the story being…

Read More



Coronavirus Tests Boost Immunology Labā€™s Volume

CEO SUMMARY: Physicians treating patients with compromisedĀ immune systems who contract the new coronavirus needĀ immunology tests to guide risk-assessment decisions for theseĀ patients. At a Virginia lab that specializes in such testing, specimenĀ volume has tripled since the SAR…

Read More



In Michigan, Short Supplies Constrain COVID Test Capacity

CEO SUMMARY: Because of a severe shortage ofĀ supplies, members of Michiganā€™s two hospital laboratoryĀ networks have been stymied in their ability to respond toĀ the pandemic and operate their SARS-CoV-2 analyzersĀ at full capacity. The lack of primers, reagents, specimen-collec…

Read More



June 1, 2020 Intelligence: Late-Breaking Lab News

Daily, national newsĀ headlines call attentionĀ to the lack of adequateĀ testing for COVID-19.Ā News reporters question whyĀ clinical labs are unable to meetĀ the demand for SARS-CoV-2Ā tests. One major reason is theĀ lack of adequate supplies labsĀ need to collect specimens,Ā transport them, and per…

Read More



Helping Labs with Cash Flow, COVID-19 Response

ROUTINE SPECIMEN VOLUME REMAINS DOWN by 50% or more for clinicalĀ laboratories and anatomic pathology groups in the United States because ofĀ the pandemic. Through the end of last week, The Dark Report estimatesĀ that labs in the U.S. have lost almost $7 billion since the first week of March…

Read More



NeoGenomics Spends $37M for Human Longevityā€™s Oncology Division

Once again, Neogenomics, Inc. is using anĀ  acquisitionĀ  toĀ  buildĀ  upĀ  its cancer-testing business. In a deal that closed on Jan. 10, the lab company acquired the Oncology Division of Human Longevity, based in San Diego. Neogenomics said it paid $37 million f…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;